SHASHANK JHA: Open Payments
NPI 1174800072 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$713 in 21 payments from 8 companies in 2025. Trend: 2023 $171 · 2024 $41 · 2025 $713
Food & beverage: $713
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $379 |
| ABBVIE INC. | 5 | $94 |
| Supernus Pharmaceuticals, Inc. | 3 | $86 |
| Neurocrine BioSciences, Inc. | 2 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Bausch Health US, LLC | 1 | $23 |
| Tris Pharma Inc | 1 | $20 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: Auvelity, VRAYLAR, Qelbree, INGREZZA, APLENZIN, Onyda XR, ABILIFY MAINTENA, CAPLYTA.
Industry payments across GA — which companies pay providers there.
